Innovative Development Focus Just Biotherapeutics specializes in cutting-edge biotherapeutic design, leveraging advanced technology to accelerate molecule development and reduce manufacturing costs, presenting opportunities for partnerships in biotech innovation and cost-effective drug production.

Strategic Partnerships The company's recent collaborations with major pharmaceutical players like Teva indicate a strong position to offer trusted biomanufacturing solutions and joint development projects, appealing to firms seeking to expand their biologics pipeline.

Funding and Growth With a substantial funding total of 71 million dollars and prior Series B financing of 57 million dollars, Just Biotherapeutics demonstrates financial backing conducive to scaling operations, creating potential for clients seeking reliable innovation partners in early-stage or expanding projects.

Technological Expertise Utilizing a robust tech stack including AWS, TensorFlow, and programming languages like Python and PHP, the company offers sophisticated data-driven solutions and automation services that can enhance bioprocessing efficiency for partners in research and manufacturing stages.

Market Positioning Positioned within the research services industry with a focus on biologics, Just Biotherapeutics is well-placed to serve mid-sized biotech firms and large pharmaceutical companies looking for innovative, cost-effective biologic development and manufacturing solutions, creating numerous sales avenues.